University of Sheffield spinout Rinri Therapeutics has collected $13.9m from investors including Boehringer Ingelheim Venture Fund and UCB Ventures.

Tectonic Therapeutic is the latest venture undertaken by Harvard’s serial entrepreneur Timothy Springer, who co-led the series A round.

GV participated in a series C round that lifted the coronavirus treatment and preventative agent developer's overall funding to $466m.

Alexandria Real Estate Equities helped the cancer detection software developer through a convertible note round.

Venture Catalysts’ accelerator has now raised $70m so far and is set to reach a final close by the end of this year.

Alchemab Therapeutics has raised $80m to advance research originating at University of Oxford, Johns Hopkins University and Mount Sinai Hospital.

E-commerce platform developer Olist added $23m to a SoftBank-backed round now topping $80m, while Waters Corporation-backed TetraScience closed its series B at $80m.

Amazon Smbhav Venture Fund will back Indian companies developing digitalisation technology for small and medium-sized businesses.

Prosus took part in a $63m round for logistics service provider Shipper while V1 Group-backed animation platform developer Laihua raised over $25m.

The Gilead Sciences-backed oncology drug developer will join forces with Nasdaq-listed BCTG in a reverse takeover deal.